The Current Strategy of Helicobacter pylori Eradication / 대한내과학회지
Korean Journal of Medicine
; : 13-21, 2021.
Article
em Ko
| WPRIM
| ID: wpr-894556
Biblioteca responsável:
WPRO
ABSTRACT
Helicobacter pylori (H. pylori) is the main cause of most gastroduodenal diseases. Triple therapy including two antibiotics, amoxicillin and clarithromycin, and a proton pump inhibitor given for a week has been recommended as the treatment of choice since the revision of the Korean H. pylori Clinical Practice Guidelines in 2013. However, antimicrobial resistance significantly decreased the cure rate of H. pylori eradication to 63.9%. Thus, the new H. pylori treatment regimen would be needed to increase the eradication rate in Korea. Recently, the update of clinical practice guideline for treatment of H. pylori was developed by conducting a meta-analysis. In this review, the recommended H. pylori eradication regimen in current 2020 guideline will be discussed.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Guideline
Idioma:
Ko
Revista:
Korean Journal of Medicine
Ano de publicação:
2021
Tipo de documento:
Article